Study Stopped
IRB recommended change to registry study or quality improvement project status
Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The objective of the study is to examine the extent to which diet/lifestyle change programs with a multidisciplinary team (consisting of a dietician, physician and behaviorist/health coach) that develop healthy behaviors before creating a calorie deficit for weight loss will result in greater weight loss and a longer duration of weight maintenance. It intends to compare the extent of weight loss and weight maintenance in participants who will undergo calorie restriction without prior behavioral interventions to participants that will undergo behavioral interventions prior to starting calorie restriction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2019
CompletedFirst Posted
Study publicly available on registry
December 9, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedJune 25, 2020
June 1, 2020
1.9 years
December 4, 2019
June 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline in body weight at 6 months
The degree of weight loss in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
6 months
Change from 6 months in body weight at 18 months
The duration of weight maintenance in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
6 months vs 18 months
Secondary Outcomes (5)
Change from baseline in blood pressure at 18 months
18 months
Change from baseline in A1c at 18 months
18 months
Change from baseline in lipid profile at 18 months
18 months
Change from baseline in medication burden (number of medications) at 18 months
18 months
Change from baseline in medication burden (dose of medications) at 18 months
18 months
Study Arms (2)
OPTIFAST only
NO INTERVENTIONControl group will consist of participants that have not undergone behavioral modifications with the Prescription for Wellness Program. These are participants that only go through the OPTIFAST Program.
UPMC PFW followed by OPTIFAST
EXPERIMENTALThe intervention group will consist of participants that have undergone behavioral modifications with the Prescription for Wellness Program. These are participants who undergo the Prescription for Wellness Program prior to the OPTIFAST Program.
Interventions
UPMC Prescription for Wellness is an innovative physician/provider prescribed coaching and feedback program that improves patient engagement and outcomes in healthy behaviors; self-care of chronic disease and condition management; and shared decision-making. The resources available through this program are offered via a telephonic health coach, online or through a digital intervention based on the participant's convenience.
Eligibility Criteria
You may qualify if:
- Male or female aged 18 yrs or older
- BMI \>40 kg/m2
- BMI between 35-40 kg/m2 with obesity-related co-morbidities including type 2 diabetes mellitus, hypertension, dyslipidemia. Type 2 Diabetes Mellitus defined by A1c \>6.4% with or without oral hypoglycemic agents and with or without insulin therapy. Hypertension defined by blood pressure \>140/80 mm of hg with or without antihypertensive therapy. Dyslipidemia defined as fasting lipid profile with one or more of the following abnormalities: serum cholesterol levels \>200 mg/dl, serum triglyceride levels \>150 mg/dl, HDL levels \<50 mg/dl, LDL levels \>100 mg/dl with or without therapy.
You may not qualify if:
- Binge eating disorder (Bulemia, Anorexia nervosa)
- Congestive heart failure NYHA Class \>3
- \>Stage 3 chronic kidney disease
- Cardiovascular disease (non-fatal MI, non-fatal stroke, peripheral vascular disease) within the past 6 months of screening
- Planned coronary artery, carotid artery or peripheral artery revascularization
- Weight loss surgery (gastric bypass, sleeve gastrectomy, total/subtotal gastrectomy) within the past 2 yrs.
- Pregnant and lactating females
- Active malignancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Rometo, M.D
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Director for UPMC Center for Obesity Medicine
Study Record Dates
First Submitted
December 4, 2019
First Posted
December 9, 2019
Study Start
January 1, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2022
Last Updated
June 25, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share